Clinical Trial Update: Urinary Excretion of Acetylamantadine by Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating urinary excretion of acetylamantadine in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Acetylamantadine (acetylamantadine)

Snippet

Sponsor: University of Manitoba | Conditions: Cancer | Phase 2 | Status: COMPLETED